检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]佳木斯市中心医院心内一科,黑龙江佳木斯154000 [2]佳木斯大学附属第一医院
出 处:《心血管康复医学杂志》2015年第2期185-188,共4页Chinese Journal of Cardiovascular Rehabilitation Medicine
摘 要:目的:探讨氯吡格雷在非ST 段抬高心肌梗死(NSTEMI)患者急诊介入治疗时的应用价值。方法:选择2012年1月~2013年2月于本院治疗的168例NSTEMI患者,随机分为氯吡格雷组(84例)与噻氯匹啶组(84例),均急诊行冠脉介入治疗。观察两组患者的临床疗效并进行对比。结果:术后28d ,与噻氯匹定组比较,氯吡格雷组TIMI 3级血流比例(88.1%比91.7%)、白细胞计数[(4.0±2.9)×109/L比(7.2±2.3)×109/L]、血小板计数[(101±35)×109/L比(141±39 )×109/L ]明显增多,轻度出血比例(40.5%比19.0%) 显著减少( P<0.05或 P<0.01);经6个月随访,与噻氯吡啶组比较,氯吡格雷组心血管事件(60.7%比27.4%)、不良反应发生率(14.3%比10.8%) 均明显降低( P均<0.05)。结论:氯吡格雷用于非S T 段抬高心肌梗死患者急诊冠脉介入治疗疗效满意,安全性高,值得推广。Objective:To explore the application value of clopidogrel in patients with non ST segment elevation myo‐cardial infarction (NSTEMI) during emergency percutaneous coronary intervention (PCI) .Methods :A total of 168 NSTEMI patients treated in our hospital from Jan 2012 to Feb 2013 were randomly divided into clopidogrel group (n=84) and ticlopidine group (n=84) ,both groups received PCI .Therapeutic effect were observed and compared be‐tween two groups .Results:Compared with ticlopidine group , there were significant rise in percentage of TIMI blood flow grade 3 (88.1% vs .91.7% ) ,white blood cell counting [ (4.0 ± 2.9) 109/L vs .(7.2 ± 2.3) 109/L] and platelet counting [ (101 ± 35) 109/L vs .(141 ± 39) 109/L] ,and significant reduction in percentage of mild bleeding (40.5% vs .19.0% ) in clopidogrel group after operation 28d , P〈 0.05 or 〈 0.01 ;compared with ticlopidine group , there were significant reductions in incidence rates of cardiovascular events (60.7% vs . 27.4% ) and adverse reactions (14.3% vs .10.8% ) in clopidogrel group after six‐month follow‐up ( P〈0.05 both) .Conclusion:Clopi‐dogrel possesses satisfying therapeutic effect and high safety in patients with non ST segment elevation myocardial in ‐ farction during emergency percutaneous coronary intervention ,which is worth extension .
分 类 号:R541.22[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.82